Molecular imaging is at the forefront of personalised medicine with several technological developments introducing a paradigm shift in the diagnosis, staging and treatment follow-up of patients. Among them, the quest for a higher sensitivity through improved Time-of-Flight PET (TOF-PET) performance and enlarged field of view with Total Body PET (TB-PET) approaches nicely complements a vigorous multimodality effort to combine the merits of PET/SPECT with MRI in single integrated systems.
As the ultimate goal is the same, namely allowing earlier diagnosis of diseases and improving their prognosis, and as several emerging technologies are of common interest for these three research lines, we have recently decided to merge the three dedicated workshop series PSMR (PET/SPECT and MR Multimodal Technologies), FTMI (Fast Timing in Medical Imaging) and TB-PET (Total Body PET) and into a single one to be organised every second year.
The first combined workshop: PSMR-FTMI-TBPET took place in May 2024 in Isola d’Elba, Italy.
We are thrilled to announce the 2d one: FTMI-TBPET-PSMR in May 11-14th 2026 at hotel Las Arenas[1], Valencia (Spain).
We are currently working on finalizing logistic details such as registration fees (and modalities), accommodation options, and the scientific program.
For interested people, this workshop will be immediately followed by the MEDAMI 2026 workshop in May 15-17th 2026 at the Terminal Hub at the Valencia harbour[2], with the theme:
Deployment of Nuclear Medicine Technologies to Low- and Medium-Income Countries
A dedicated indico web page will be open soon for each of these two workshops, with more relevant information. For the time being, book these days in your agenda! We are looking forward to welcoming you in Valencia in May 2026.
For the organizing committee
Antonio J. Gonzalez
Paul Lecoq
Technical program committee
● Nicola Belcari, INFIN Pisa, Italy
● Simon Cherry, UC Davis, Davis, USA
● Maurizio Conti, Siemens, Knoxville, USA
● Antonio J. Gonzalez, I3M (CSIC/UPV), Valencia, Spain
● Andrea Gonzalez-Montoro, I3M (CSIC/UPV), Valencia, Spain
● Paul Lecoq, I3M (CSIC/UPV), Valencia, Spain, and Metacrystal SA., Geneva, Switzerland
● Jae Sung Lee, Seoul National University College of Medicine, Seoul, South Korea
● Robert Miyaoka, University of Washington, USA
● Magdalena Rafecas, Lübeck University, Germany
● Andrew Reader, King's College London, UK
● Kuangyu Shi, Universitätsspital Bern, Switzerland
● Dimitris Visvikis, University of Brest, France
● Stefan Vandenberghe, Ghent University, Belgium
Local Organizing committee
● Antonio J. Gonzalez, I3M (CSIC/UPV), Valencia, Spain
● Paul Lecoq, I3M (CSIC/UPV), Valencia, Spain, Metacrystal SA. and CERN, Geneva, Switzerland
● Marta Freire, I3M (CSIC/UPV), Valencia, Spain
● Fiammetta Pagano, I3M (CSIC/UPV), Valencia, Spain
● Patricia Sanjuan, Turevents & Go, Valencia, Spain
● Daniela Alvarado, Turevents & Go, Valencia, Spain
